Skip to content
New Jersey Could Change Marijuana Drug Testing Rules for Safety-Sensitive Workers in 2027

New Jersey Could Change Marijuana Drug Testing Rules for Safety-Sensitive Workers in 2027

New Jersey Could Change Marijuana Drug Testing Rules for Safety-Sensitive Workers in 2027

Senate Bill S4685 proposes significant exceptions to New Jersey's existing cannabis employment protections — what construction, transportation, and public safety employers need to watch now.

DrugScreens.com  |  October 20, 2026  |  Legislative Update

⚠ Proposed legislation only — S4685 remains in committee as of October 2026. No changes to New Jersey employer obligations are in effect yet.

Quick Answer

New Jersey Senate Bill S4685, introduced October 1, 2026, proposes to carve out significant exceptions to the state's existing recreational cannabis employment protections. If enacted, the bill would allow employers to prohibit recreational cannabis use, conduct random drug testing, and take adverse employment action based on positive THC results — but only for specified safety-sensitive positions including law enforcement officers, first responders, CDL drivers, and heavy-equipment operators. As of October 2026, S4685 remains in committee and is not law. Employers should monitor its progress and begin reviewing whether their current drug testing panels and written policies align with where New Jersey law may be heading.

What New Jersey Law Currently Says About Cannabis and Employment

New Jersey legalized adult recreational cannabis use in 2021 under the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization (CREAMMA) Act. Under current law, New Jersey employers generally cannot take adverse employment action against an employee solely because they use cannabis lawfully outside of work hours.

Key provisions of current New Jersey cannabis employment law include:

  • Employers cannot refuse to hire, discharge, or otherwise penalize an employee solely based on lawful off-duty recreational cannabis use
  • Employers may still prohibit cannabis use during work hours and on employer property
  • Employers may test for cannabis if an employee appears impaired at work, following a workplace accident, or as part of a federally mandated testing program
  • Federal contractors and safety-sensitive federal positions remain subject to federal law regardless of state protections

The challenge for many New Jersey employers — particularly in construction, transportation, and public safety — is that current state law limits testing and adverse action even for positions where impairment poses serious safety risks. S4685 is a direct legislative response to that tension.

For a deeper look at how cannabis employment law interacts with workplace drug testing decisions across the country, see our guide on cannabis and workplace drug testing: the employer's guide to 2027.

New Jersey Cannabis Employment Law: Current vs. Proposed Under S4685 Side-by-side comparison of current New Jersey employer cannabis testing rights versus what S4685 would allow for safety-sensitive positions NJ Cannabis Employment Law: Current vs. S4685 Proposed Employer Action Current NJ Law S4685 Proposed (Safety-Sensitive) Prohibit off-duty cannabis use For recreational users ✗ Generally not permitted ✓ Permitted Random cannabis drug testing Without impairment observation ✗ Generally not permitted ✓ Permitted Adverse action on positive THC result Discipline, termination, or demotion ✗ Restricted ✓ Permitted Pre-employment cannabis screening For specified safety-sensitive roles Limited / role-dependent ✓ Explicitly permitted Federal contractor / DOT positions CDL drivers, federally regulated roles ✓ Federal law applies ✓ Federal law applies

What S4685 Proposes: The Key Provisions

Senate Bill S4685, introduced by New Jersey legislators on October 1, 2026, would create a distinct legal framework for employers operating in safety-sensitive industries — carving out meaningful exceptions to the general CREAMMA protections that currently limit cannabis-related adverse employment action.

The bill's core provisions, as analyzed by employment law firm Ogletree Deakins in their October 19, 2026 review:

  • Covered positions: Law enforcement officers, first responders (including firefighters and EMS personnel), commercial driver's license (CDL) holders, and heavy-equipment operators
  • Off-duty use prohibition: Employers in covered industries could prohibit recreational cannabis use even outside of working hours — a significant departure from current CREAMMA protections
  • Random testing authorization: Employers could implement random New Jersey marijuana drug testing programs for covered employees without requiring observed impairment as a trigger
  • Adverse action on positive result: A positive cannabinoid metabolite result could support discipline, termination, or other adverse action for covered positions
  • Pre-employment screening: Employers could screen applicants for cannabis for specified safety-sensitive roles before hire
Legislative status: As of October 2026, S4685 remains in committee. It has not been enacted. Employers should monitor its progress but should not alter existing written drug testing policies based on proposed legislation alone. Consult qualified employment counsel before making any policy changes.

Which Employers Should Pay Closest Attention

If S4685 advances, the employers most directly affected will be those whose workforce includes the specified covered positions. Several industries stand out:

Construction companies employing heavy-equipment operators — crane operators, forklift operators, and equipment operators working on job sites — would gain new authority to test and act on positive THC results. For construction employers already navigating OSHA safety obligations, this alignment of state testing authority with federal safety requirements has been a long-standing ask.

Transportation companies and staffing agencies with CDL drivers in New Jersey currently benefit from federal DOT testing authority for those drivers specifically — but S4685 would extend similar testing rights to non-federally regulated positions within the same workforce, reducing the compliance complexity of maintaining split testing policies.

Municipal employers, police departments, and fire departments employing law enforcement officers and first responders would gain explicit statutory authority for random NJ employee THC testing programs — something many have sought since recreational cannabis legalization created ambiguity about testing programs for public safety personnel.

Staffing agencies placing workers in safety-sensitive client sites face a particular compliance challenge: the same employee may be covered or not covered depending on the role and client site. S4685 would clarify the testing authority for covered placements but would not resolve the complexity of managing covered and non-covered workers under a single drug testing program.

Key policy insight: The same drug testing policy may be legally appropriate for one position but create liability for another — even within the same company and same state. Written drug testing policies should define covered positions explicitly and reference applicable legal authority for each testing type used.

THC-Inclusive vs. THC-Free Testing Panels: Matching the Test to the Position

One practical implication of S4685 — and of the broader national trend toward position-specific cannabis testing rules — is that New Jersey employers may need to maintain different drug testing panels for different employee classifications. A one-size panel approach creates both legal exposure and operational inefficiency when the legal authority to test for THC varies by position.

Understanding the available options:

Panel Type THC Included? Best For (NJ Context)
Standard 5-Panel (SAMHSA-5) Yes Federal contractor roles, DOT-regulated CDL drivers, positions where THC testing is legally authorized
Expanded Multi-Panel (10–16 panel) Yes Safety-sensitive positions (if S4685 passes); opioid and synthetic drug monitoring; high-risk worksites
THC-Free Panel No General workforce positions in NJ where CREAMMA protections apply; employers who choose not to test for cannabis regardless of legal authority

Product selection should always follow the employer's applicable legal requirements and their written drug testing policy — not the other way around. DrugScreens.com carries both multi-panel urine drug test cups with THC included and drug test panels without THC for employers whose policy or legal obligations require THC-excluded testing.

Drug Testing Products for New Jersey Safety-Sensitive Employers

Whether your New Jersey workforce currently uses THC-inclusive panels under federal authority or you are evaluating your options ahead of potential S4685 enactment, DrugScreens.com carries CLIA-waived urine drug test cups suited to safety-sensitive employer programs:

6-PANEL / NO THC

Non-THC 6-Panel Oral Fluid Saliva Test

✓ Employment & Insurance Use

Oral fluid saliva test with saturation indicator — screens for 6 substances without THC. Ideal for NJ employers whose written policy excludes cannabis testing under CREAMMA general workforce protections.

View Product
9-PANEL / NO THC

SAFElife 9-Panel Non-THC T-Dip CLIA-Waived

✓ CLIA Waived

Rapid urine dip card covering 9 substances without THC — CLIA-waived and suited for New Jersey employers who need broad drug screening while excluding the cannabinoid panel from general workforce positions.

View Product
10-PANEL

SafeLife 10-Panel T-Cup Urine Drug Test

✓ CLIA Waived

Expanded 10-panel coverage including THC, opiates, benzodiazepines, and methadone — well-suited for construction, transportation, and public safety employer programs where broader substance monitoring is required.

View Product
5-PANEL / NO THC

Drug Test Panels Without THC

✓ CLIA Waived Options Available

For New Jersey employers whose written policy excludes cannabis testing for general workforce positions under CREAMMA protections — THC-free panels covering opiates, cocaine, amphetamines, and other substances without the cannabinoid screen.

Shop THC-Free Panels
MULTI-PANEL

StatCup Flat-Sided Urine Drug Test Cups

✓ CLIA Waived

Flat-sided design for easy labeling and documentation — a practical choice for construction and transportation employers running high-volume pre-employment or random safety-sensitive testing programs.

Shop StatCup
MULTI-PANEL

SafeLife Urine Drug Test Cup Collection

✓ CLIA Waived

Full range of SafeLife CLIA-waived urine cups from 5-panel through expanded panels — for employers building or updating safety-sensitive drug testing programs in New Jersey and beyond.

Shop SafeLife

What New Jersey Employers Should Do Now

S4685 is proposed legislation — not law. But its introduction signals a shifting legislative environment for safety-sensitive drug testing in New Jersey, and the groundwork employers lay now will determine how quickly they can adapt if the bill advances.

Recommended steps for New Jersey employers in construction, transportation, and public safety:

  • Audit your current written drug testing policy — does it clearly define which positions are covered, which testing types are authorized (pre-employment, random, reasonable suspicion, post-accident), and under what legal authority?
  • Identify which positions are already covered by federal testing authority — DOT-regulated CDL drivers and federal contractors remain subject to federal drug testing requirements regardless of state law; confirm those programs are current
  • Review your panel selections by position — positions where THC testing is currently legally authorized should use THC-inclusive panels; positions subject to CREAMMA general protections may require THC-free panels
  • Monitor S4685 in committee — Ogletree Deakins and the New Jersey Legislature's official bill tracking page are the authoritative sources for legislative status updates
  • Consult employment counsel before changing any policies — policy changes made in anticipation of proposed legislation that does not pass can create compliance exposure under current law

Building or Updating a Safety-Sensitive Drug Testing Program?

DrugScreens.com supplies CLIA-waived urine drug test cups for construction, transportation, public safety, and other safety-sensitive employer programs — with both THC-inclusive and THC-free panel options to match your written policy and legal requirements.

Shop Drug Test Cups

 

This content is provided for general informational purposes only and does not constitute legal advice, regulatory guidance, or IRB or compliance consultation. DrugScreens.com supplies drug screening devices and does not provide laboratory services, medical diagnostics, IRB guidance, or drug testing program administration. Research teams should consult with their IRB, institutional compliance office, principal investigator, and qualified legal and regulatory counsel before implementing any drug screening protocol.

This content is for general informational and educational purposes only and should not be considered medical, legal, or diagnostic advice. DrugScreens.com is an eCommerce supplier of drug testing kits and supplies and does not perform or provide drug testing services, laboratory analysis, or medical diagnostics.

Cart 0

Your cart is currently empty.

Start Shopping